Moya, E
Mzembe, G
Mwambinga, M
Truwah, Z
Harding, R
Ataide, R
Larson, Leila M
Fisher, J
Braat, S
Pasricha, SR
Mwangi, MN
Phiri, KS
Article History
Received: 16 November 2022
Accepted: 6 March 2023
First Online: 5 April 2023
Declarations
:
: The two protocols for REVAMP study and REVAMP Observational cohort were approved by the College of Medicine Research and Ethics Committee, Malawi and the Walter and Eliza Hall Institute of Medical Research Ethics Committee, Australia. All study procedures were conducted in accordance with the International Conference on Harmonisation Guidelines for good clinical practice and the Declaration of Helsinki. All participants were given information about the study and written informed consent was obtained from all study participants for participation in the study. For participants aged 17 years or less, we sought a written informed consent from the parents or legal guardians and assent from the participants.
: Not applicable.
: All authors declare no competing interests.